Ejhaem
Overview
Ejhaem is a scientific journal, published since 2020 in English. The journal's country of origin is United States and its primary focus area is hematology.
Details
Details
Abbr.
EJHaem
Start
2020
End
Continuing
Frequency
Monthly
e-ISSN
2688-6146
Country
United States
Language
English
Specialty
Hematology
Recent Articles
1.
Uchino K, Nakagami Y, Enotomoto M, Shimizu N, Kondo K, Yamamoto T, et al.
EJHaem
. 2025 Mar;
6(2):e70017.
PMID: 40078599
No abstract available.
2.
Giusti G, Jotta P, de Oliveira Lopes C, Migita N, de Azevedo A, Brandalise S, et al.
EJHaem
. 2025 Mar;
6(2):e70003.
PMID: 40066131
Biased VDJ recombination has been previously described in childhood B-cell precursor acute lymphoblastic leukemia (BCP-ALL), although its causes are not yet fully understood. This study assesses differential features in 565...
3.
Smith C, Goyal A, Smith B, Lee D, Jensen A, Alexander J, et al.
EJHaem
. 2025 Mar;
6(2):e270011.
PMID: 40066130
Introduction: Richter's transformation (RT) from chronic lymphocytic leukemia (CLL) to lymphoma carries poor prognosis. This case series examines the efficacy of lisocabtagene maraleucel (liso-cel) in six RT patients, highlighting the...
4.
Agrawal S, Bapat A, Eades C, Gandhi S
EJHaem
. 2025 Mar;
6(2):e1105.
PMID: 40066129
Objective: To examine the incidence of invasive fungal disease (IFD) in patients receiving targeted agents for acute myeloid leukaemia (AML). Methods: Literature for this systematic review was identified through a...
5.
Iyer P, Hudson C, Sohail K, Mihailescu L, Bolam S
EJHaem
. 2025 Mar;
6(2):e70013.
PMID: 40052019
No abstract available.
6.
Mitsuyuki S, Okazaki S, Mukai S, Matsuura A, Yasuhara Y, Tanaka A, et al.
EJHaem
. 2025 Mar;
6(2):e1082.
PMID: 40052018
Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) has a high relapse rate. However, it typically remains confined to the skin and has a favorable long-term prognosis. We describe a case...
7.
Shea L, Narkhede M, Chamarti K, Gao T, Mehta A, Goyal G
EJHaem
. 2025 Mar;
6(2):e1099.
PMID: 40041663
Introduction: Little is known about long-term outcomes and causes of death for individuals with cutaneous T-cell lymphoma. Methods: We used SEER-18 registry data to examine outcomes among 9886 adults with...
8.
Jager P, Biermann B, Liebers N, Schulz F, Baermann B, Twarock S, et al.
EJHaem
. 2025 Mar;
6(2):e70012.
PMID: 40041662
Background: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a key treatment for hematologic malignancies, but donor selection impacts outcomes. Results: In a cohort of 152 patients undergoing allo-SCT from 2012...
9.
Foy P, Higa S, Zhao J, Keapoletswe K, Cirneanu L, Venerus A, et al.
EJHaem
. 2025 Mar;
6(2):e70009.
PMID: 40034869
No abstract available.
10.